InKaryo Overview
- Year Founded
-
2013

- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
InKaryo General Information
Description
Provider of cytogenetic analysis services intended to serve the healthcare sector. The company's experimental protocol and proprietary bioinformatics analysis cover the full genome evenly with specific and accurate digital sequence output thus providing next-generation sequencing platforms, sequencing reagents, sequencing applications, genomic diagnostics and bioinformatics.
Contact Information
Website
www.inkaryo.comCorporate Office
- 2318-C Walsh Avenue
- Santa Clara, CA 95051
- United States
Corporate Office
- 2318-C Walsh Avenue
- Santa Clara, CA 95051
- United States
InKaryo Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
InKaryo FAQs
-
When was InKaryo founded?
InKaryo was founded in 2013.
-
Where is InKaryo headquartered?
InKaryo is headquartered in Santa Clara, CA.
-
What industry is InKaryo in?
InKaryo’s primary industry is Outcome Management (Healthcare).
-
Is InKaryo a private or public company?
InKaryo is a Private company.
-
What is the current valuation of InKaryo?
The current valuation of InKaryo is
. -
What is InKaryo’s current revenue?
The current revenue for InKaryo is
. -
When was InKaryo acquired?
InKaryo was acquired on 19-Mar-2015.
-
Who acquired InKaryo?
InKaryo was acquired by Esperite.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »